In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020 | Zendy

James A. Karlowsky | Zendy; Sibylle Lob | Zendy; C Andrew DeRyke | Zendy; David W. Hilbert | Zendy; Michael T. Wong | Zendy; Katherine Young | Zendy; Fakhar Siddiqui | Zendy; Mary Motyl | Zendy; Daniel F. Sahm | Zendy

Open Access

In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020

Author(s) -

James A. Karlowsky,

Sibylle Lob,

C Andrew DeRyke,

David W. Hilbert,

Michael T. Wong,

Katherine Young,

Fakhar Siddiqui,

Mary Motyl,

Daniel F. Sahm

Publication year - 2022

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00189-22

Subject(s) - ceftazidime/avibactam , broth microdilution , microbiology and biotechnology , pseudomonas aeruginosa , imipenem , ceftazidime , biology , avibactam , carbapenem , minimum inhibitory concentration , antibiotic resistance , antimicrobial , antibiotics , bacteria , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research